Tc99mDMSAIIIRadiochemicalPurityChecker
Tc-99m DMSA(III) Radiochemical Purity Checker
Utility description: Tc-99m DMSA(III) Radiochemical Purity Checker
Tc-99m DMSA(III) Radiochemical Purity Checker — Technetium-99m DMSA(III) for renal scintigraphy
ℹ️ Utility checks critical parameters of Tc-99m DMSA(III):
• Radiochemical purity (≥90-95%)
• Free pertechnetate (≤5%)
• Reduced/hydrolyzed technetium (≤5%)
• Aluminum oxide (<5 ppm)
• pH (4.0-7.0)
• Endotoxins (<175 EU/mL)
• Sterility, heavy metals, stability time (≤4 hours)
⚠️ CRITICAL: Low RCP <90% → accumulation in thyroid gland and stomach!
Free pertechnetate >5% → false imaging results!
Stability time exceedance >4h → complex degradation and reduced efficacy!
Usage:
Tc99mDMSAIIIRadiochemicalPurityChecker.exe → demo mode (console output)
Tc99mDMSAIIIRadiochemicalPurityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation
Example (sterility: 0=sterile, 1=contaminated):
TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0
— WHY IS THIS NEEDED?
Technetium-99m DMSA(III) — widely used radiopharmaceutical for renal cortical visualization:
• 6.02-hour half-life — optimal for diagnostics
• 140 keV gamma radiation — ideal for gamma cameras
• High affinity for renal cortex (cortical visualization)
• Clinically proven efficacy in kidney function assessment, scarring, pyelonephritis
⚠️ CRITICAL:
• Radiochemical purity ≥90-95% — ensures specific accumulation in kidneys
• Free pertechnetate ≤5% — free Tc-99m accumulates in thyroid, stomach, and salivary glands, creating artifacts
• Reduced/hydrolyzed technetium ≤5% — colloidal technetium is taken up by reticuloendothelial system (liver, spleen)
• Aluminum oxide <5 ppm — excess Al³⁺ disrupts complexation and reduces RCP to 99.5-99.69%
• pH 4.0-7.0 — critical for DMSA complex stability and prevention of dissociation
• Endotoxins <175 EU/mL — critical for IV administration!
• Sterility — MANDATORY for all parenteral forms!
• Usage time ≤4 hours — complex is unstable, oxidation and dissociation occur
Key features:
• Radiochemical purity check (main quality parameter)
• Control of two main impurities: free pertechnetate and reduced technetium
• Aluminum oxide monitoring as critical labeling quality factor
• pH control for complex stability assurance
• Time since preparation check (critical for short-lived isotopes)
• Comprehensive microbiological safety assessment
Critical parameters:
• Radiochemical purity: ≥90.0% (optimal ≥95%)
• Free pertechnetate: ≤5.0%
• Reduced/hydrolyzed technetium: ≤5.0%
• Aluminum oxide: <5.0 ppm
• pH: 4.0–7.0
• Endotoxins: <175 EU/mL
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
• Stability time: ≤4 hours
💡 Usage tips:
1. Radiochemical purity controlled by TLC or HPLC with radio-detector
2. Free pertechnetate determined on silica gel strips (mobile phase: acetone)
3. Colloidal technetium determined on paper (mobile phase: saline)
4. Aluminum controlled by colorimetric method or ICP-MS
5. All measurements should be performed within 4 hours after synthesis
6. If RCP <90% — batch rejected (critical parameter for clinical use)!
⚠️ Note: Tc-99m DMSA(III) is one of the most important diagnostic radiopharmaceuticals for nephrology. Low radiochemical purity leads to false-positive results (accumulation in thyroid, stomach) and reduced diagnostic value. Quality control must be performed before each use.input.csv
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0 TC99M-DMSA-2026-002,92.0,3.5,4.2,4.8,6.2,120.0,0,8.0,3.5 TC99M-DMSA-2026-003,88.0,6.5,5.8,6.2,7.5,200.0,1,12.0,5.0
URS & FS — user requirements and functional specification
URS — User Requirements Specification
- The utility shall accept
input.csvwith the headers defined by the data contract. - Before calculation, the utility shall detect missing fields, type errors and invalid values.
- The utility shall deterministically perform “Tc-99m DMSA(III) Radiochemical Purity Checker”.
- The checks shall include the following criteria: Radiochemical purity: ≥90.0% (optimal ≥95%); Free pertechnetate: ≤5.0%; Reduced/hydrolyzed technetium: ≤5.0%; Aluminum oxide: <5.0 ppm; pH: 4.0–7.0; Endotoxins: <175 EU/mL; Sterility: no microbial growth; Heavy metals: ≤10 ppm; Stability time: ≤4 hours.
- Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
- The result shall be written to
output.jsonand retain the source values used for the checks. - The result supports batch-data review; release remains with authorised QA/QC personnel.
FS — Functional Specification
- Run
Tc99mDMSAIIIRadiochemicalPurityChecker.exein demo mode or withinput.csv output.jsonarguments. - Read UTF-8 CSV and validate the header and mandatory columns.
- Convert values to the expected types and validate admissibility.
- Perform the calculation or rule checks for “Tc-99m DMSA(III) Radiochemical Purity Checker”.
- Create individual check results and the overall status.
- Write machine-readable JSON; invalid input shall not appear as a successful result.
input.csv example
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation TC99M-DMSA-2026-001,97.5,1.2,1.3,2.5,5.5,50.0,0,3.0,2.0
Minimum output.json structure
{
"utility": "Tc99mDMSAIIIRadiochemicalPurityChecker",
"source": "input.csv",
"status": "PASS|WARNING|FAIL",
"checks": [
{
"parameter": "example",
"status": "PASS",
"message": "criterion satisfied"
}
],
"errors": []
}
Before operational use
- Limits and coefficients shall be approved before operational use.
- After an executable or rule change, repeat the affected tests.
- Retain the source CSV and JSON result together in the controlled process.
Included in packages
Radiopharmaceutical Diagnostics and Therapy QC Suite
36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.
OpenRPH isotope family: Tc-99m
Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite
16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.
OpenRPH use case: Tc-99m renal and nephrourology
Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: instruments, devices and radiation safety
PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
Open